William Blair & Company
IVA

William Blair & Company’s Inventiva IVA Stock Holding History

William Blair & Company’s Portfolio IVA Stock Details IVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55.5K Buy
+10,000
New +$61K ﹤0.01% 1686

Other funds holding IVA

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

William Blair & Company's IVA Position: Q1 2026 in Review

William Blair & Company opened a new position in Inventiva (IVA) in Q1 2026: 10,000 shares worth $55.5K. The stake represents ﹤0.01% of the portfolio and ranks #1686 among its holdings.

65 funds tracked by Wall St. Rank hold IVA as of Q1 2026.

  • William Blair & Company held 10,000 shares of Inventiva worth $55.5K as of Q1 2026.
  • Inventiva was a new William Blair & Company position in Q1 2026.
  • Inventiva made up ﹤0.01% of William Blair & Company's portfolio in Q1 2026, its #1686 holding.
  • 65 funds tracked by Wall St. Rank held Inventiva as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.